Russia COVID-19 vaccine 'passes early trial test'

Kelly Macnamara (Agence France-Presse) - September 5, 2020 - 11:20am LONDON, United Kingdom — Early tests of a Russian coronavirus vaccine showed encouraging results when details were published Friday, but experts said the trials were too small to prove safety and effectiveness. Russia announced last month that its vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval. This raised concerns among Western scientists over a lack of safety data, with some warning that moving too quickly on a vaccine could be dangerous. Russia denounced criticism as an attempt to undermine Moscow's research and a Russian investor claimed vindication when Britain's prestigious Lancet published research that showed patients in early tests developed antibodies with "no serious adverse events." In the Lancet study, Russian researchers reported on two small trials, each involving 38 healthy adults aged between 18 and 60, who were given a two-part immunization. Each participant was given a dose of the first part of the vaccine and then given a booster with the second part 21 days later. They were monitored over 42 days and all developed antibodies within the first three weeks. The report said the data showed that the vaccine was "safe, well tolerated, and does not cause serious adverse events in healthy adult volunteers". The trials were open label and not randomised, meaning there was no placebo and the participants knew they were receiving the vaccine and were not randomly assigned to different treatment groups. Researchers underlined that larger and longer trials -- including a placebo comparison -- would be needed to establish the long-term safety and effectiveness of the vaccine for preventing Covid-19 infection. The report said the 76 participants of these trials would be monitored up to 180 days, adding that a more rigorous phase 3 clinical trial was planned with the involvement of 40,000 volunteers "from different age and risk groups". 'Powerful response to the skeptics' Kirill Dmitriev, who heads a Russian investment fund behind the vaccine, told an online news conference in Moscow that the Lancet publication "is a powerful response to the skeptics who unreasonably criticised the Russian vaccine." Independent experts were still cautious. Naor Bar-Zeev of Johns Hopkins Bloomberg School of Public Health, who was not involved in the study, said the research was "encouraging but small", adding that it did not give any data on effectiveness among older age groups, who are particularly vulnerable to Covid-19. "Showing safety will be crucial with Covid-19 vaccines, not only for vaccine acceptance but also for trust in vaccination broadly," he said in a commentary in the Lancet. "Since vaccines are given to healthy people and, during the Covid-19 pandemic, potentially to everyone after approval following phase 3 trials, safety is paramount." The pandemic has seen an unprecedented mobilisation of funding and research to rush through a vaccine that can protect billions of people worldwide. This week the US urged states to get ready for a potential Covid-19 vaccine rollout two days before the presidential election in November, sparking concerns President Donald Trump's administration is accelerating research to fit a political timetable. 'International market' goal Russia has said that industrial production of its version is expected from September. President Vladimir Putin said in early August that the vaccine gave "sustainable immunity" and that one of his own daughters had been inoculated, even though Russia's health ministry said clinical trials were not yet complete. The World Health Organization has urged Russia to follow established guidelines and go "through all the stages" necessary to develop a safe vaccine. Sputnik V was developed by the Gamaleya research institute for epidemiology and microbiology in Moscow in coordination with the Russian defence ministry. It uses a cold-causing adenovirus, which is then modified and combined with a part of the new coronavirus, SARS-CoV-2. The report's lead author, Denis Logunov of Gamaleya, said the adenovirus vaccine enters people's cells and delivers the SARS-CoV-2 spike protein genetic code, helping the immune system "recognise and attack" the virus. Dmitriev said vaccine production "will initially be aimed at a Russian market, but we hope to have the possibility to supply the vaccine to an international market," signalling interest from around 40 countries. The WHO insisted it would never endorse a vaccine that has not proven safe and effective and also said it did not expect widespread immunization against the novel coronavirus until mid-2021. The organization said a total of 176 potential vaccines were being developed worldwide, including 34 being tested on people. Among those eight are at stage three, the most advanced.

Comments

Post a Comment

Popular posts from this blog

PCG: China’s bullying in West Philippine Sea undermines international law --- Ghio Ong - The Philippine Star

MANILA, Philippines — Letting China sustain its aggression in the West Philippine Sea would make other countries doubt the strength of international law currently being asserted by the Philippines, Commodore Jay Tarriela of the Philippine Coast Guard (PCG) said. “Allowing China to blatantly disregard the established rules-based order threatens the very foundation that we all depend on,” he wrote in a post on X last Tuesday. He added, “If we permit this, countries worldwide may forget why this order was created in the first place. Nations could begin to doubt the significance of adhering to international law if powerful bullies can easily violate it.” Tarriela also said defiance of other countries to a rules-based order would result in the prevalence of cruelty. He wrote, “This could lead us back to a time when might makes right, undermining the global structures that keep human greed, savagery and barbarism in check. Such a scenario would not only invite challenges from aggressive ...
Read more

China ships maintain presence in key West Philippine Sea areas --- Michael Punongbayan - The Philippine Star

STAR / Michael Varcas MANILA, Philippines — While Chinese vessels in the West Philippine Sea (WPS) have decreased in number, they have maintained a presence in three key land features where naval and coast guard ships have intensified operations in the past seven days, according to the Philippine Navy. Latest monitoring by the Philippine Navy showed armed ships of the People’s Liberation Army Navy (PLAN) maintaining a menacing presence around the grounded BRP Sierra Madre in Ayungin Shoal, Panatag Shoal and Escoda Shoal. According to the Philippine Navy, there are 17 Chinese military vessels and 28 China Coast Guard (CCG) boats spotted inside the country’s exclusive economic zone (EEZ) between Sept. 23 and 30, or one vessel more than in the previous week Sept.17-23. Five of the warships were seen roaming around the vicinity of Escoda Shoal, along with 10 CCG vessels and 12 maritime militia vessels (MMVs). There are also two PLAN ships in Ayungin Shoal as well as 10 CCG boats and 12...
Read more

Social media seen as cause of rising intermarriages --- Helen Flores - The Philippine Star

MANILA, Philippines — The Commission on Filipinos Overseas (CFO) sees social media as the main reason for the rising number of Filipinos marrying or becoming partners of foreign nationals. In 2022, the CFO recorded 6,854 marriages or partnerships with foreign nationals, a 40.1 percent increase from the 4,891 “intermarriages” recorded in 2021. “First of all, what we see in the increase in the marriage rate of Filipinos or Filipinos with foreign partners is because of social media, (that) is number one; matchings; letters, introduction of their friends,” CFO chairperson Romulo Arugay said at the Bagong Pilipinas Ngayon public briefing yesterday. Arugay said the agency has been registering a high number of intermarriages since 2007, but the figures went down during the COVID-19 pandemic. From over 6,500 Filipinos who married foreign nationals, only 600 are men, he said. Most of them are married to Americans, Japanese, Germans, Canadians and Australians, Arugay said. Arugay warned Fi...
Read more